Ann M. Saunders

41.9k citations

177 papers · 31.5k indexed · 12 hit papers · h-index 61

Impact in

Physiology top 0.01%
- Alzheimer's disease research and treatments
Psychiatry and Mental health top 0.05%
- Dementia and Cognitive Impairment Research

Papers in

Physiology 100
- Alzheimer's disease research and treatments 96
Psychiatry and Mental health 51
- Dementia and Cognitive Impairment Research 47

Co-authors: Allen D. Roses Warren J. Strittmatter D. E. Schmechel Jeffery M. Vance Gary W. Small Elizabeth H. Corder P. C. Gaskell J. L. Haines
Journals: Alzheimer s & Dementia (28 papers)Neurology (10 papers)Proceedings of the National Academy of Sciences (8 papers)Journal of Neuropathology & Experimental Neurology (6 papers)Genomics (5 papers)
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Ann M. Saunders

174 papers receiving 30.5k citations

Hit Papers

12 papers align trajectories log scale

Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways 2008 · 779 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Journal of Alzheimer s Disease
2006 The Pharmacogenomics Journal
2003 Proceedings of the National Academy of Sciences
2000 New England Journal of Medicine
2000 Proceedings of the National Academy of Sciences
1998 Archives of Neurology
1994 Nature Genetics
1993 Proceedings of the National Academy of Sciences
1993 Proceedings of the National Academy of Sciences
1993 Neurology
1993 Science
1993 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Ann M. Saunders

Since Specialization

Citations

This map shows the geographic impact of Ann M. Saunders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann M. Saunders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann M. Saunders more than expected).

Fields of papers citing papers by Ann M. Saunders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann M. Saunders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann M. Saunders. The network helps show where Ann M. Saunders may publish in the future.

Co-authors

The 25 scholars most cited alongside Ann M. Saunders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ann M. Saunders Line = papers co-authored together Ann M. Saunders links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TOMM40 ‘523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOE ɛ3 Homozygotes Journal of Alzheimer s Disease ·Amber Watts, Stephen Haneline, Kathleen A. Welsh‐Bohmer, Jingtao Wu, Robert Alexander, Russell H. Swerdlow, Daniel K. Burns, Ann M. Saunders	2023	1
2	Disease-modifying effects of an SCAF4 structural variant in a predominantly SOD1 ALS cohort Neurology Genetics ·S. Badiuzzaman, Loren L. Flynn, Ryan S. Anderton, Frank Mastaglia, Li Jiu Wang, Ian James, Abigail L. Pfaff, Sulev Kõks, Ann M. Saunders, Richard Bedlack, Daniel K. Burns, Michael W. Lutz, Nailah Siddique, Teepu Siddique, Allen D. Roses, P. Anthony Akkari	2020	8
3	Journal of Parkinson’s disease & Alzheimer’s disease PubMed ·William Gottschalk, Michael W. Lutz, Yu He, Ann M. Saunders, Daniel K. Burns, Allen D. Roses, Ornit Chiba‐Falek	2014	67
4	The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes European Neuropsychopharmacology ·Lior Greenbaum, Tamsin Kashap, Michael W. Lutz, Anthony Heymann, Tauqir Mohsin Mehmood, Itzik Cooper, Efrat Kravitz, Mary Sano, Allen D. Roses, Jeremy M. Silverman, Ann M. Saunders, Michal Schnaider Beeri	2014	22
5	TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial Alzheimer s & Dementia ·Allen D. Roses, Michael W. Lutz, Donna G. Crenshaw, Iris Grossman, Ann M. Saunders, William Gottschalk	2013	53
6	Longitudinal modeling of cognitive aging and the TOMM40 effect Alzheimer s & Dementia ·Richard J. Caselli, Amylou C. Dueck, Matthew J. Huentelman, Michael W. Lutz, Ann M. Saunders, Eric M. Reiman, Allen D. Roses	2012	58
7	Characterization of the Poly-T Variant in the TOMM40 Gene in Diverse Populations PLoS ONE ·Colton L. Linnertz, Ann M. Saunders, Michael W. Lutz, Bhanu Richa Duggirala, Iris Grossman, Daniel K. Burns, Keith E. Whitfield, Michael A. Hauser, Jeanette McCarthy, Megan Ulmer, Rand Allingham, Kathleen A. Welsh‐Bohmer, Allen D. Roses, Ornit Chiba‐Falek	2012	46
8	P4‐299: Effects Of Rosiglitazone‐extended Release As Adjunctive Therapy To Acetylcholinesterase Inhibitors Over 48 Weeks On Cognition In Apoe4‐stratified Subjects With Mild‐to‐moderate Alzheimer's Disease Alzheimer s & Dementia ·Conn Harrington, Sharon Sawchak, Carl Chiang, John T. Davies, Ann M. Saunders, Michael C. Irizarry, Marina Zvartau‐Hind, Christopher van Dyck, Michael Gold	2009	7
9	A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease The Pharmacogenomics Journal ·Allen D. Roses, Michael W. Lutz, Heather Amrine‐Madsen, Ann M. Saunders, Donna G. Crenshaw, Scott S. Sundseth, Matthew J. Huentelman, Kathleen A. Welsh‐Bohmer, Eric M. Reiman	2009	288
10	Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease The Pharmacogenomics Journal ·Marcus E. Risner, Ann M. Saunders, Валентина Ивановна Знойкина, George C. Ormandy, Suzanne Craft, I. Foley, Marina Zvartau‐Hind, David A. Hosford, A D Roses, (unknown) Hit paper breakdown →	2006	548
11	Ordered-Subsets Linkage Analysis Detects Novel Alzheimer Disease Loci on Chromosomes 2q34 and 15q22 The American Journal of Human Genetics ·William K. Scott, Elizabeth R. Hauser, Donald E. Schmechel, Kathleen A. Welsh‐Bohmer, Gary W. Small, Allen D. Roses, Ann M. Saunders, John R. Gilbert, Jeffery M. Vance, Jonathan L. Haines, Margaret A. Pericak‐Vance	2003	82
12	The Q7R Saitohin gene polymorphism is not associated with Alzheimer disease Neuroscience Letters ·Sofia A. Oliveira, Eden R. Martin, William K. Scott, Kristin K. Nicodemus, Gary W. Small, Donald E. Schmechel, P. Murali Doraiswamy, Allen D. Roses, Ann M. Saunders, John R. Gilbert, Jonathan L. Haines, Jeffery M. Vance, Margaret A. Pericak‐Vance	2003	11
13	Cognitive Function and Apolipoprotein E in Very Old Adults RePEc: Research Papers in Economics ·Kathryn Riley, David A. Snowdon, Ann M. Saunders, Allen D. Roses, James A. Mortimer, Nuwan D. Nanayakkara	2000	4
14	The role of apolipoprotein E in Alzheimer’s disease: pharmacogenomic target selection Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Ann M. Saunders, Marek Lajda, Richard A. Shimkets, Levent DEĞİRMENCİOĞLU, Daniel Crowther, Traci A. Mansfield, Donald M. Wallace, Warren J. Strittmatter, Allen D. Roses	2000	72
15	Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K) Neuroscience Letters ·Janet M. Grubber, Ann M. Saunders, Andrés Felipe Cadavid Toro, William K. Scott, Eden R. Martin, Carol Haynes, P.M. Conneally, Gary W. Small, Allen D. Roses, Jonathan L. Haines, Margaret A. Pericak‐Vance	1999	32
16	Cis-Acting Human ApoE Tissue Expression Element is Associated with Human Pattern of Intraneuronal ApoE in Transgenic Mice Neurobiology of Aging ·Allen D. Roses, James Gilbert, Pu Xu, Patrick M. Sullivan, Brian Popko, D Burkhart, Miomir Arsić, Ann M. Saunders, Nobuo Maeda, D. E. Schmechel	1998	19
17	No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease Genetic Epidemiology ·William K. Scott, Larry H. Yamaoka, P. A. Locke, B.L. Rosi, P. C. Gaskell, Ann M. Saunders, P.M. Conneally, Gary W. Small, Lindsay A. Farrer, John H. Growdon, Allen D. Roses, Margaret A. Pericak‐Vance, Jonathan L. Haines	1997	28
18	Apolipoprotein E genotype and Lewy body disease Neurology ·Carol F. Lippa, Thomas W. Smith, Ann M. Saunders, Richard Crook, D. Pulaski-Salo, Peter Davies, John Hardy, Allen D. Roses, Dennis W. Dickson	1995	69
19	Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. Journal of Clinical Investigation ·David A. Sanan, Karl H. Weisgraber, Stephen J. Russell, Robert W. Mahley, David Huang, Ann M. Saunders, D. E. Schmechel, Thomas Wısnıewskı, Blas Frangione, Allen D. Roses	1994	335
20	Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families Science ·Elizabeth H. Corder, Ann M. Saunders, Warren J. Strittmatter, D. E. Schmechel, P. C. Gaskell, Gary W. Small, Allen D. Roses, J. L. Haines, Jeffery M. Vance Hit paper breakdown →	1993	7044

About Ann M. Saunders

Ann M. Saunders is a scholar working on Physiology, Psychiatry and Mental health, Pharmacology, Neurology and Neurology, having authored 177 papers that have together received 31.5k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (96 papers), Dementia and Cognitive Impairment Research (47 papers), Cholinesterase and Neurodegenerative Diseases (25 papers), Bioinformatics and Genomic Networks (22 papers), Computational Drug Discovery Methods (16 papers), Mitochondrial Function and Pathology (14 papers), Nuclear Receptors and Signaling (11 papers) and Parkinson's Disease Mechanisms and Treatments (10 papers). The work is most often cited by research in Physiology (19.6k citations), Psychiatry and Mental health (7.9k citations), Neurology (4.0k citations), Biological Psychiatry (811 citations) and Cellular and Molecular Neuroscience (4.2k citations). Ann M. Saunders has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Allen D. Roses, Warren J. Strittmatter, D. E. Schmechel, Jeffery M. Vance, Gary W. Small, Elizabeth H. Corder, P. C. Gaskell, J. L. Haines, A D Roses and Guy S. Salvesen. Their work appears in journals such as Alzheimer s & Dementia, Neurology, Proceedings of the National Academy of Sciences, Journal of Neuropathology & Experimental Neurology and Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact